FR2337712A1 - Analogues nouveaux de prostaglandines - Google Patents

Analogues nouveaux de prostaglandines

Info

Publication number
FR2337712A1
FR2337712A1 FR7700428A FR7700428A FR2337712A1 FR 2337712 A1 FR2337712 A1 FR 2337712A1 FR 7700428 A FR7700428 A FR 7700428A FR 7700428 A FR7700428 A FR 7700428A FR 2337712 A1 FR2337712 A1 FR 2337712A1
Authority
FR
France
Prior art keywords
prostaglandins
new analogues
analogues
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7700428A
Other languages
English (en)
Other versions
FR2337712B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2337712A1 publication Critical patent/FR2337712A1/fr
Application granted granted Critical
Publication of FR2337712B1 publication Critical patent/FR2337712B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7700428A 1976-01-08 1977-01-07 Analogues nouveaux de prostaglandines Granted FR2337712A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/647,357 US4055602A (en) 1976-01-08 1976-01-08 2-Decarboxy-2-hydroxy-methyl-5-oxa-17-phenyl-18,19,20-trinor-PGF-analogs

Publications (2)

Publication Number Publication Date
FR2337712A1 true FR2337712A1 (fr) 1977-08-05
FR2337712B1 FR2337712B1 (fr) 1983-05-20

Family

ID=24596656

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7700428A Granted FR2337712A1 (fr) 1976-01-08 1977-01-07 Analogues nouveaux de prostaglandines

Country Status (9)

Country Link
US (20) US4055602A (fr)
JP (1) JPS5289649A (fr)
AU (1) AU502587B2 (fr)
BE (1) BE850204A (fr)
CH (1) CH627725A5 (fr)
DE (1) DE2659215A1 (fr)
FR (1) FR2337712A1 (fr)
NL (1) NL7700117A (fr)
ZA (1) ZA767465B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353290A1 (fr) * 1975-08-13 1977-12-30 Upjohn Co Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
US4638100A (en) * 1976-01-08 1987-01-20 The Upjohn Company Aromatic or inter-oxa 2-decarboxy-2-hydroxymethyl-PGFα compounds
US4208538A (en) * 1976-01-08 1980-06-17 The Upjohn Company 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-ω-phenyl-PGF2 compounds
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
US5030621A (en) * 1987-04-23 1991-07-09 Bystryn Jean Claude Shed melanoma antigen compositions
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US20030060878A1 (en) 2001-08-31 2003-03-27 Shadduck John H. Intraocular lens system and method for power adjustment
US8048155B2 (en) 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US7217288B2 (en) 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US7637947B2 (en) 2002-12-12 2009-12-29 Powervision, Inc. Accommodating intraocular lens system having spherical aberration compensation and method
US8361145B2 (en) 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
EP1599748A4 (fr) 2003-03-06 2007-10-24 John H Shadduck Lentille optique adaptative et procede de fabrication
US7306580B2 (en) * 2003-04-16 2007-12-11 Cook Incorporated Medical device with therapeutic agents
EP2423158A1 (fr) 2004-03-24 2012-02-29 H. C. Starck Inc Procédés de formation de films de tantale alpha et bêta avec des microstructures nouvelles et contrôlées
US20060292324A1 (en) * 2004-03-26 2006-12-28 Robert Roberts Uniaxially and biaxially-oriented polytetrafluoroethylene structures
US7183310B2 (en) * 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7906552B2 (en) * 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
AU2008218313B2 (en) 2007-02-21 2014-01-09 Alcon Inc. Polymeric materials suitable for ophthalmic devices and methods of manufacture
US8314927B2 (en) * 2007-07-23 2012-11-20 Powervision, Inc. Systems and methods for testing intraocular lenses
EP2647353B1 (fr) 2007-07-23 2014-12-31 PowerVision, Inc. Système de mise en place de lentille
EP2178463B1 (fr) 2007-07-23 2013-09-04 PowerVision, Inc. Accommodation de lentilles intraoculaires
CN101795642B (zh) 2007-07-23 2013-11-27 力景公司 植入后晶状体放大率修正
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
EP2454227B1 (fr) 2009-07-13 2020-08-19 Patheon API Services Inc. Synthèse de prostanoïdes
WO2011026068A2 (fr) * 2009-08-31 2011-03-03 Powervision, Inc. Estimation de la taille de la capsule du cristallin
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
EP2539351B1 (fr) 2010-02-23 2017-07-12 PowerVision, Inc. Fluide pour recevoir des lentilles intraoculaires
WO2012006616A2 (fr) 2010-07-09 2012-01-12 Powervision, Inc. Dispositif de pose de lentilles intraoculaires et leurs procédés d'utilisation
EP2688515B1 (fr) 2011-03-24 2021-05-19 Alcon Inc. Procédé de chargement d'une lentille intra-oculaire dans un dispositif d'injection
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
US10195020B2 (en) 2013-03-15 2019-02-05 Powervision, Inc. Intraocular lens storage and loading devices and methods of use
KR102311896B1 (ko) 2013-09-30 2021-10-14 패턴 에이피아이 서비시즈 인코포레이티드 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로
JP7063815B2 (ja) 2015-11-06 2022-05-09 アルコン インコーポレイティド 調節型眼内レンズおよび製造する方法
CA3152310A1 (fr) 2019-10-04 2021-04-08 Terah Whiting Smiley Lentilles intraoculaires reglables et procedes de reglage postoperatoire de lentilles intraoculaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959346A (en) * 1969-03-14 1976-05-25 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
US3914282A (en) * 1973-01-16 1975-10-21 Upjohn Co Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353290A1 (fr) * 1975-08-13 1977-12-30 Upjohn Co Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant

Also Published As

Publication number Publication date
FR2337712B1 (fr) 1983-05-20
US4107213A (en) 1978-08-15
AU502587B2 (en) 1979-08-02
US4108900A (en) 1978-08-22
US4107211A (en) 1978-08-15
US4108903A (en) 1978-08-22
US4110382A (en) 1978-08-29
US4113778A (en) 1978-09-12
US4107212A (en) 1978-08-15
AU2077176A (en) 1978-06-29
JPS5289649A (en) 1977-07-27
US4055602A (en) 1977-10-25
DE2659215A1 (de) 1977-07-21
US4127733A (en) 1978-11-28
US4107215A (en) 1978-08-15
US4108902A (en) 1978-08-22
US4111995A (en) 1978-09-05
US4107216A (en) 1978-08-15
US4108901A (en) 1978-08-22
ZA767465B (en) 1977-11-30
US4115454A (en) 1978-09-19
NL7700117A (nl) 1977-07-12
US4110384A (en) 1978-08-29
BE850204A (fr) 1977-07-07
US4107214A (en) 1978-08-15
US4110383A (en) 1978-08-29
US4110381A (en) 1978-08-29
CH627725A5 (de) 1982-01-29
US4111996A (en) 1978-09-05

Similar Documents

Publication Publication Date Title
BE850204A (fr) Analogues nouveaux de prostaglandines
BE857761A (fr) Analogues de prostaglandines et leur preparation
FR2317915A1 (fr) Analogues de prostaglandines et leur preparation
BE846340A (fr) Analogues de prostaglandines et leur preparation
BE850203A (fr) Nouveaux analogues de prostaglandines
BE846876A (fr) Nouveaux analogues des prostaglandines et leur preparation,
FR2336924A1 (fr) Analogues de prostaglandines et leur preparation
BE825459A (fr) Nouveaux derives de prostaglandines
BE856099A (fr) Nouveaux analogues de prostaglandines et leur preparation
FR2337713A1 (fr) Analogues de prostaglandines
BE854271A (fr) Analogues de prostaglandines et leur preparation
BE824196A (fr) Prostaglandines
BE851303A (fr) Nouveaux derives bicycloalkyliques de prostaglandines
BE857482A (fr) Nouveaux analogues de cephalosporines
BE851357A (fr) Analogues des prostaglandines
FR2299022A1 (fr) Antagonistes de prostaglandines
FR2320084A1 (fr) Analogues de prostaglandines
BE853801A (fr) Analogues de prostaglandines et leur preparation
FR2351100A1 (fr) Nouveaux analogues de prostaglandines
PT64737A (fr) Prostaglandin analogues
BE835430A (fr) Nouveaux analogues des prostaglandines
BE857161A (fr) Nouveaux analogues de prostaglandines et leur preparation
BE856739A (fr) Composes analogues aux prostaglandines
BE834915A (fr) Analogues de prostaglandines
BE852363A (fr) Analogues de prostaglandines

Legal Events

Date Code Title Description
ST Notification of lapse